Death Valley: Why So Many Good Technologies Never Make It to Market

The valley of death of innovation is the trough between the end of R&D and the first revenues. This is the time when public funding becomes less accessible, when private capital waits for evidence of traction, and when the leap in scale requires new investment. Crossing it requires three projects carried out together: securing cash flow, validating the contract and carrying out the transition from the prototype to a manufacturable or saleable solution.

The scenario is known to many innovators. Proof of concept works. Technology delivers on its promises. Yet, somewhere between the prototype and the first sale, the project slows down, runs out of steam, or finds itself without sufficient resources to continue. It’s not always a technical failure. It is often a problem of passage: between two shores, research on one side and the market on the other.

Understanding this phase early on helps to avoid undergoing it. Promising technology doesn’t get through this trough just because it’s good; it crosses it because the financing, the contract and the industrial or commercial execution have been prepared together.

Defining the Valley of Death

Death Valley refers to the phase where a technology has left research, but has not yet reached a level of revenue, traction, or commercial evidence sufficient to naturally attract investors or fund its growth through its own sales.

R&D is behind you. The revenue is in front of you. Between the two, expenses increase: validation, industrialization, pilot tests, compliance, first sales, business development, intellectual property, partnerships. This is when the company is particularly vulnerable: it has already invested a lot, but it has not yet demonstrated everything that the market expects.

This is one of the most common causes of failure in innovation journeys, not because technology has no value, but because the transition from invention to commercial adoption is rarely funded, structured, and executed far enough in advance.

How do you know if your project is entering the valley of death?

The dip does not always start suddenly. It often manifests itself in an accumulation of weak signals that the team initially interprets as simple delays.

• The prototype or proof of concept works, but the first revenues are slow to arrive.
• The R&D programs no longer really cover the next expenses, because the project enters validation, pilot or pre-commercialization.
• Investors or partners ask for more proofs of market before committing.
• Scaling up to pilot, industrial or commercial scale requires resources that the company has not yet secured.
• The team continues to improve the technology, but the plan for marketing, financing or partnerships remains unclear.

These signals do not mean that the project is doomed. Rather, they indicate that we need to change the logic: no longer just develop technology, but organize its passage to the market.

Why this hollow exists

The valley of death is not an accident. It is born from the meeting of three logics that often leave the same moment uncovered.

Public funding often stops at the threshold of R&D

Most public programs first fund technical uncertainty, research, development, or technology validation. Once the proof of concept has been established, the nature of the project changes: it must finance scale-up, pilot testing, commercialization, compliance or the first series. These expenses may be eligible for certain levers, but they require a different set-up and a more precise schedule.

Private capital awaits evidence

Private investors want market signals: customers, revenue, strong letters of intent, traction, sales pipeline, credible partners. However, this evidence costs time and money to obtain. The paradox is classic: you are asked to prove the market to get the money that would prove it.

Scaling up is expensive

Between the laboratory and the market, it is often necessary to finance equipment, pilot tests, validations, documentation, initial production or technical adaptations. The time when the project needs the most capital is often when it is most difficult to finance.

The three ditches to cross together

The valley of death cannot be crossed with a single lever. It adds up three gaps that must be treated in parallel.

• The funding gap : Maintaining cash flow while expenses increase and revenues remain uncertain.
• The market gap : turning a business intuition into a demand confirmed by real customers, partners or buyers.
• The technical gap : successfully scaling up without losing the performance, quality or profitability of the technology.

Moving forward on a single front is not enough. A well-funded technology without a market eventually runs out. Demand that is confirmed but impossible to produce at scale creates a dead end. A solid technology without a financing plan is blocked before it has a chance to prove itself.

How to Cross Death Valley

The dip is not inevitable. Companies that go through it build a transition plan: they identify the evidence to be obtained, the financing to be sequenced, the risks to be reduced and the partners to be mobilized before cash flow becomes the only issue.

1. Rely on non-dilutive financing

Before selling shares at the most fragile moment, it is first necessary to assess the available non-dilutive leverage. Tax credits such as SR&ED and CRIC, NRC-IRAP contributions, the ESSOR and Innovation programs, and certain pre-commercialization levers can extend the financial track. However, their eligibility depends on the specific nature of the work, the schedule, the expenses and the stage of the project.

Good editing is not about stacking programs. It consists of sequencing them: financing R&D at the right time, preparing for market validation, supporting the pilot phase, and then organising marketing without creating unfavourable interactions between aid, credits and eligible expenditure.

2. Validate the market early, not at the end

The best time to confirm the request is before you need it to raise funds. A market validation conducted during technical development allows you to arrive in the valley with evidence: documented customer conversations, confirmed problems, priority segments, purchase intent, potential partners, early pilots or letters of interest.

This validation is not a substitute for technology. It gives him a commercial direction. It makes it possible to decide which functionalities, which proofs and which uses should be prioritized to convert an invention into a purchasable solution.

3. Execute the Scale Break with Method

The transition to pilot scale and then to manufacturing must be treated as a step in its own right. It is necessary to identify critical parameters, document risks, test limits, anticipate costs and involve the right industrial or commercial partners. This is the heart of the transition from design to commercialization.

A poorly prepared scaling jump can quickly consume the remaining resources. Conversely, a structured transition reduces technical risk, reassures partners, and creates the evidence needed to secure funding or customers.

Building a passage plan

Crossing the valley of death requires a short, concrete and revisable roadmap. It must answer five questions:

• What technical evidence remains to be produced to reassure the market or partners?
• What business evidence should be obtained before seeking private financing?
• What non-dilutive levers can support each step of the journey?
• Which partners, manufacturers, distributors or pilot customers should be mobilized?
• What timeline helps reduce risk before cash flow becomes critical?

This roadmap transforms a dangerous trough into a sequence of decisions. It does not guarantee success, but it avoids confusing technological development, financing and commercialization in the same fog.

The role of support

Crossing the valley of death means orchestrating several projects at a time when the company has the least margin of error. The support provides a technical, financial and market reading: sequencing the right financing, preparing commercial proofs, securing the leap in scale and clarifying the next decisions.

Progrès Conseils supports innovators in this critical transition thanks to an expertise combining R&D financing, technology commercialization, market validation and project structuring. The objective is not only to find a program, but to build a coherent transition plan between R&D and the first revenues.

Is your technology promising, but the path to revenue isn’t clear? Let’s talk about your transition to the market : we can help you diagnose the gaps to be crossed (financing, market, scale-up) and clarify the levers to activate to move forward.